Ahmad Raise, Luka Marine, Journe Anne-Sophie, Gallet Sarah, Hegron Alan, Do Cruzeiro Marcio, Millan Mark J, Delagrange Philippe, Masri Bernard, Dam Julie, Prevot Vincent, Jockers Ralf
Université Paris Cité, Institut Cochin, INSERM, CNRS, Paris, France.
University Lille, Inserm, CHU Lille, Lille Neuroscience and Cognition, Lille, France.
J Pineal Res. 2025 Mar;77(2):e70041. doi: 10.1111/jpi.70041.
Human genetic variants of the orphan G protein-coupled receptor GPR50 are suggested risk factors for neuropsychiatric disorders. However, the function of GPR50 in the central nervous system (CNS) and its link to CNS disorders remain poorly defined. Here, we generated GPR50 knockout (GPR50-KO) mice and show that the absence of GPR50 increases neurite outgrowth, cell motility and migration of isolated neural progenitor cells (NPCs) and hypothalamic radial glial cells (tanycytes). These observations were phenocopied in NPCs and tanycytes from wild-type mice treated with neutralizing antibodies the against the prototypical neurite growth inhibitor Nogo-A. Treatment of NPCs and tanycytes from GPR50-KO cells with neutralizing antibodies had no further, additive, effect. Inhibition of neurite growth by GPR50 occurs through activation of the G protein-RhoA pathway in a manner similar to, but independent of Nogo-A and its receptors. Collectively, we show that GPR50 acts as an inhibitor of neurite growth and cell migration in the brain by activating the G protein-RhoA pathway.
孤儿G蛋白偶联受体GPR50的人类遗传变异被认为是神经精神疾病的风险因素。然而,GPR50在中枢神经系统(CNS)中的功能及其与CNS疾病的联系仍不清楚。在此,我们生成了GPR50基因敲除(GPR50-KO)小鼠,并表明GPR50的缺失增加了神经突生长、细胞运动以及分离的神经祖细胞(NPC)和下丘脑放射状胶质细胞(伸展细胞)的迁移。在用针对典型神经突生长抑制剂Nogo-A的中和抗体处理的野生型小鼠的NPC和伸展细胞中也出现了这些现象。用中和抗体处理GPR50-KO细胞的NPC和伸展细胞没有进一步的叠加效应。GPR50对神经突生长的抑制作用是通过激活G蛋白-RhoA途径实现的,其方式与Nogo-A及其受体类似,但相互独立。我们的研究结果共同表明,GPR50通过激活G蛋白-RhoA途径,在大脑中作为神经突生长和细胞迁移的抑制剂发挥作用。